from the United States Court of Appeals for the Third Circuit
See other cases from the Third Circuit.
Petition DENIED.
Supplemental brief of petitioners SmithKline Beecham Corporation, dba GlaxoSmithKline, et al. filed. (Distributed)
Brief amicus curiae of United States filed.
The Solicitor General is invited to file a brief in this case expressing the views of the United States.
Reply of petitioners SmithKline Beecham Corporation, dba GlaxoSmithKline, et al. filed.
Brief of respondents King Drug Company of Florence, Inc., et al. in opposition filed.
Brief amicus curiae of Allergan PLC filed.
Brief amici curiae of Washington Legal Foundation, et al. filed.
Brief amicus curiae of Pharmaceutical Research and Manufacturers of America filed.
Brief amicus curiae of Generic Pharmaceutical Association filed.
Brief amicus curiae of National Association of Manufacturers filed.
Order extending time to file response to petition to and including May 2, 2016.
Response Requested . (Due April 1, 2016)
Waiver of right of respondents King Drug Company of Florence, Inc., et al. to respond filed.
Petition for a writ of certiorari filed. (Response due March 23, 2016)
Application (15A603) granted by Justice Alito extending the time to file until February 20, 2016.
Application (15A603) to extend further the time from January 21, 2016 to February 20, 2016, submitted to Justice Alito.
Application (15A603) granted by Justice Alito extending the time to file until January 21, 2016.
Application (15A603) to extend the time to file a petition for a writ of certiorari from December 22, 2015 to February 20, 2016, submitted to Justice Alito.
SmithKline Beecham Corporation, dba GlaxoSmithKline, et al., Petitioner, represented by Jay P. Lefkowitz
King Drug Company of Florence, Inc., et al., Respondent, represented by Bruce E. Gerstein
Allergan PLC, Amicus Curiae, represented by J. Mark Gidley
Generic Pharmaceutical Association, Amicus Curiae, represented by Melissa Arbus Sherry
National Association of Manufacturers, Amicus Curiae, represented by Daniel Simon Francis
Pharmaceutical Research and Manufacturers of America, Amicus Curiae, represented by Mark W. Mosier
United States, Amicus Curiae, represented by Ian Heath Gershengorn
Washington Legal Foundation, et al., Amicus Curiae, represented by Richard A. Samp